HSA Grow

The impact of ChatGPT in healthcare is an intriguing topic for many domain experts. If ChatGPT can cut down on wait times in the waiting rooms i'm all for it. #hsapay

ChatGPT can provide critical assistance in the following areas

Clinical Support
Improvement in patient Awareness
Active Remote Monitoring
Enhanced Customer Service
Improve Medical Staff Productivity
Assistance Medical Score

Although at this time ChatGPT is the rage in every industry the need for sophisticated datasets will drive the value proposition for new products across the healthcare landscape, especially with the restrictions of HIPAA and PII. This being the case the greatest deployments for ChatGPT will be realized in asymmetric industries where FinTech and Healthcare collide.

👀 to HSAPAY for groundbreaking innovation in this space.

82% of HSA Holders don't know the can Invest

I get it, slow & steady wins the race when it comes to investing !! But not knowing that you can invest in stocks, bonds, ETFs, options and more with your HSA means you aren't in the race at all. Not sure if you are in the race? Check with us. #hsapay #invest

Soaring Insulin Prices are being slashed by 70%

As insulin prices have soared, this manufacturer announces it will reduce costs by 70%. HSA members suffering from diabetes your prayers have finally been answered. #diabetes #healthcare #hsapay

Healthcare is secretly consuming our thoughts!

US healthcare: terminology, appealing denial, and Medicaid eligibility — Brainwane has assembled a great current resource on Medicaid . The by-product of overly complex and confusing terms has led to increases in deferral of treatment by patients. #HSAPY

The Drive to Adopt Digital Therapeutics: Where do we Stand?

As regulatory processes and reimbursements are refined, there needs to be a continued focus on how to maximize the benefits for patients and ensure DTx can play a role in improving outcomes.

The healthcare industry is undergoing continuous changes with the emergence of technological advancements that provide a more comprehensive understanding of a patient's health, ultimately leading to improved outcomes. In recent times, the adoption of telehealth and remote patient monitoring (RPM) has witnessed a significant increase. As these technologies become more prevalent in mainstream healthcare delivery, what lies ahead in the realm of digital health technology? A promising area is digital therapeutics (DTx), which has gained momentum with several products gaining FDA approval for various indications. However, while almost 40 DTx products have gained acceptance among consumers, there are still issues concerning regulations, integration into the clinical workflow, and wider adoption that require further exploration to enhance patient care and outcomes.

Digital Therapeutics (DTx) are software solutions and medical devices that are based on solid evidence and clinical validation. They are designed to help patients manage their health conditions effectively. DTx can help prevent, manage, or treat medical disorders or diseases. They can be a combination of software, device, or drug or just software. These solutions cater to a range of health concerns such as mental health conditions, obesity, heart disease, diabetes, asthma, chronic obstructive pulmonary disease (COPD), pain, post-traumatic stress disorder, and more. DTx solutions are different from the consumer wellness apps found on your phone. They are developed following industry standards for clinical efficacy, usability, and data security.

High-cost Pharmacy Claims, Medical Inflation Among Top Threats for Employers

When asked what the biggest threats facing them were, 94% of employers said high-cost pharmacy claims, 91% said medical inflation and 91% said million dollar treatments being approved by the FDA, according to a new survey from the Midwest Business Group on Health.

In 2022, a survey was conducted online where 57 self-insured employers participated. The survey shed light on the top concerns of employers, which include managing specialty drugs and high-cost pharmacy claims. Cheryl Larson, CEO of Midwest Business Group on Health, suggested that employers must be vigilant and audit their carriers and PBMs to mitigate the risks associated with high-cost pharmacy claims. Employers are employing various strategies to manage pharmacy benefit costs, with 74% focusing on payment reform to manage specialty drugs, 72% directing members to lower cost drugs, and 66% optimizing pharmacy benefit manager contracts. These strategies have proved to be effective in cost management and will continue to be the focus of employers in the future.

“Top threats to employers continue to be high-cost pharmacy claims and managing specialty drugs. As such, employers must focus on watching the hen house by making sure to audit their carriers and PBMs for high-cost pharmacy claims,” said Cheryl Larson, president and CEO of Midwest Business Group on Health, in an email.

Apple stock outlook: Morgan Stanley sees upside to $180

Apple Inc (NASDAQ: AAPL) is currently up about 20% versus the start of the year but a Morgan Stanley analyst says the stock could go further up in the coming months. On Friday, Erik Woodring dubbed the iPhone maker a “top pick” and raised his price objective to $180 that represents about a 25% upside on its previous close.

The analyst agreed that near-term Apple stock could struggle with challenges but said: We see a catalyst-rich event path over the next 12 months that’s underappreciated by investors, including reaccelerating iPhone and Services growth, record gross margins, two new product launches.

The tech behemoth could also soon launch an iPhone subscription programme that he said would further create room for shares to the upside.

Here's how much money you'd have if you invested $1,000 in Costco 10 years ago

🛍️As food prices continue to rise, shoppers are looking for ways to stretch their money. Luckily, Costco is benefiting from this trend! The wholesale giant now has 123 million cardholders, a 7% increase from last year.💳 📈Although Costco missed analysts' revenue prediction of $55.54 billion, it still reported earnings per share (EPS) of $3.30, beating analysts' expectations of $3.21.🎉 🤔While Costco currently has no plans to raise its annual membership fees, shoppers should be prepared for a potential increase in the future. CFO Richard Galanti stated that it's only a matter of time before fees go up.⏰

If you had invested $1,000 into Costco a year ago, your investment would be worth about $898 as of March 3, according to CNBC’s calculations.

If you had invested $1,000 into Costco five years ago, your investment would have more than doubled to $2,639 as of March 3, according to CNBC’s calculations.

And if you had put $1,000 into Costco a decade ago, it would have swelled to $5,124 as of March 3, according to CNBC’s calculations.

Time in the market is the key here, to note as a smart shopper you could have doubled down on your investment by using your HSA at the Costco Pharmacy and Optometrist. These savings over a decade could have flatten your bill and fattened your portfolio. #HSAPAY

Income and Yield for CSHI and SPYI on ETF IQ

🌟 CSHI is an amazing fund that's all about options and actively managed investments. It loves to hold long positions in three-month Treasuries while also selling cool out-of-the-money SPX Index put spreads that roll weekly. It's always on the lookout for market changes and volatility, so it can deliver 100-150 basis points above what 90-day Treasuries are yielding. Plus, it's super savvy when it comes to tax-loss harvesting opportunities and the tax efficiency of index options. 🤑 The best part? CSHI has a distribution yield of 5.66% as of 02/28/2023! That's higher than cash, but still low on the volatility scale.

🎉 Let's talk about the NEOS S&P 500 High Income ETF (SPYI) 📈! This awesome fund replicates the S&P 500 Index and uses a laddered covered call strategy to maximize returns. As of 02/28/23, it has a great 12.06% distribution yield 💰. The fund writes call options to earn premiums, which it reinvests in buying long, out-of-the-money call options on the S&P 500 Index 📈. NEOS actively manages the call options to capture gains or minimize losses.

ETF Issuer League: Vanguard Hovering Near $2 Trillion

💰 Vanguard is a big player in the asset management world, but it's not the top dog 🐶 in the ETF game 📈. According to the ETF Issuer League table, iShares has a slightly larger AUM of $2.2 trillion, while Vanguard comes in at $1.97 trillion 💪. However, both companies are still way ahead of the competition, with no other firm having crossed the $1 trillion AUM mark 🤑. State Street's SPDR suite is in third place, with $936 million in AUM. For the week ending March 2, iShares saw -$1.3 billion in outflows, while SPDR had the biggest outflows of -$1.9.

🎉 iShares had a good week with three ETFs adding over $1 billion in inflows, led by the iShares Short Treasury Bond ETF (SHV) with almost $1.4 billion. However, they were only able to secure fourth place. 🤑 JPMorgan Chase was relatively unaffected by outflows from its ETFs, which helped them to have a net gain on the week. 😍 Nevertheless, the iShares Russell 200 ETF (IWM) saw outflows of -$1.4 billion.

Consider Short-Term Treasuries While Yields Are High and Risk Is Low

💸 Investors are pouring money into investment-grade corporate fixed income, but some bond managers worry that the risks aren't worth the yields if a recession hits. 📉 Morningstar's Sandy Ward suggests that corporate bonds may experience downgrades or defaults during a downturn, so it's wise to consider short-term Treasuries instead. 📈 Currently, short-dated U.S. government bonds offer yields that compete with investment-grade fixed income. For example, six-month Treasury notes yield over 5.10%, while one-year Treasuries yield over 5.0%. While the payouts are slightly lower, the inherent risk is also lower. Choose wisely! 💰💡

Copper price bounces as China provides much needed support

Copper price continued its steady recovery after the strong economic numbers from China, its biggest consumer. It spiked to a high of $4.12, the highest point since February 23rd.Other commodities with China’s exposure like silver and iron ore also drifted upwards.

🚀💰Copper prices skyrocketed on Wednesday after China released impressive economic data. According to Caixin, China's manufacturing PMI rose to 52.6 in February, marking the most significant increase in a decade📈. A PMI score of 50 and above is a positive sign👍. The upcoming National People's Congress is also contributing to the surge in copper prices📊. The Communist Party of China will set goals for the year and provide stimulus to achieve them. Analysts predict the government's GDP target for the year will be 5%, an excellent figure after a 3% expansion in 2022.🎯

Mike Maloney on the gold rush that “will take your breath away”

During the past month, the international gold price was pummelled, reaching near a 2-month low.At the time of writing, the gold continuous contract was trading 5.5% lower over the past month.

🌎📈🤑 It's clear that the world has more buying power and market access now than it did 40 years ago. In the past, countries like the former USSR and China didn't participate in global markets, and Africa and South America didn't have developed bullion exchanges. But now, with the emphasis on de-dollarization and alternative modes of international payments, along with inflationary periods, there are more opportunities for growth. China is even pushing for de-dollarization! 🤑💰💸 Despite gold's recent lackluster performance, experts believe that the underlying factors driving the bull market of a lifetime are undeniable.

And with the ratio of derivatives to actual physical metal so lopsided, now could be the time to make a big move toward adding Gold to your HSA

Osisko Metals: Developing High-grade Base Metal Assets in Canada to Meet Future Demand

🔍 Osisko Metals (TSXV:OM) is laser-focused on two exciting base metal assets in Canada 🇨🇦, as the demand for base metals is expected to continue to increase. The company's Gaspé Copper and Pine Point projects target copper and zinc, both critical minerals for the global transition to clean energy. 🌍💡 👀 Both assets are past-producing, brownfield assets that provide significant potential for future production. The Gaspé Copper project in Quebec has a rapid development plan to begin mining the inferred 456 million tonnes of ore at 0.31 percent sulfide copper. 🚀 💪 As the gap between available copper supply and growing demand widens

DISCLAIMER: None of this is financial advice. This newsletter is strictly educational and is not investment advice or a solicitation to buy or sell any assets or to make any financial decisions. Please be careful and do your own research.

Share the gift of the best & only HSA newsletter with friends, family, and colleagues. https://sendfox.com/hsagrow